Research and Development

Showing 15 posts of 9618 posts found.

richard_cm_jones

Mereo BioPharma appoint Richard Jones as CFO

November 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mereo BioPharma

Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …

Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review

November 14, 2016 Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia

The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …
top_ten_1

Top Ten articles in the Pharma Industry this week

November 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …
ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …
shutterstock_157775444

Social media and mobile apps: Bringing people and clinical trials together

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …

Pfizer’s breast cancer drug gets EU approval

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …
novavax

Novavax cuts works force by a third in struggle to restructure

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
apps_mobile

Chinese FDA releases “drug scanner” app

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …
janssen_stairs

Collaboration on new therapeutic vaccine for HIV shows promise

November 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …

Pfizer to shut two out of three manufacturing plants in UK

November 9, 2016 Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …
amgen_hq

NICE turns down Amgen’s multiple myeloma drug

November 9, 2016 Research and Development, Sales and Marketing Amgen, Kyprolis, NICE

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …
valeant

Valeant’s tough year gets worse with Q3 loss of $1.22 billion

November 9, 2016 Research and Development Q3, Valeant, loss

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …
code

BenevolentAI announces licensing agreement with Janssen

November 8, 2016 Research and Development Janssen, Johnson & Johnson, artificial intelligence

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …
irina_antonijevic_image

Irina Antonijevic appointed as chief medical officer at vasopharm

November 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …
The Gateway to Local Adoption Series

Latest content